Testicular gonadoblastoma

disease
On this page

Also known as gonadoblastoma of testistesticular gonadoblastoma (disease)testis gonadoblastoma

Summary

Testicular gonadoblastoma (MONDO:0002698) is a disease. A subtype of testicular sex cord-stromal neoplasm — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

FieldValue
Canonical nametesticular gonadoblastoma
Mondo IDMONDO:0002698
DOIDDOID:3579
NCITC39911
UMLSC1515283
MedGen272839
GARD0023215
Anatomy (UBERON)UBERON:0000473
Is cancer (heuristic)no

Also known as: gonadoblastoma of testis · testicular gonadoblastoma · testicular gonadoblastoma (disease) · testis gonadoblastoma

Data availability: 1 HPO phenotype.

Disease family

Classification path: disease › human disease › disease by body system or component › reproductive system disorder › reproductive system neoplasm › sex cord-stromal tumor › testicular sex cord-stromal neoplasm › testicular gonadoblastoma

Related subtypes (9): testicular lymphoma, Sertoli-Leydig cell tumor, testicular Leydig cell tumor, testicular granulosa cell tumor, testicular fibroma, testicular thecoma, testicular sertoli cell tumor, testicular fibrothecoma, testicular sex cord-stromal benign neoplasm

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.